Table 2.
Multivariable logistic regression model of the risk of remission at last follow-up (n = 47 of 60)
| Variables | Univariable model |
Multivariable model |
||
|---|---|---|---|---|
| OR (95% CI) | P value of type III test | OR (95% CI) | P value of type III test | |
| Follow-up period (mo)a | 1.01 (0.99–1.03) | 0.4609 | 1.01 (0.98–1.03) | 0.6110 |
| MN stagesa | 0.1082 | 0.1416 | ||
| I | 1 | 1 | ||
| II | 0.52 (0.09–2.91) | 0.72 (0.11–4.62) | ||
| III–IV | 0.15 (0.02–0.99) | 0.12 (0.01–1.18) | ||
| EXT statusa | 0.0194 | 0.0142 | ||
| Negative | 1 | 1 | ||
| Positive | 12.52 (1.50–104.12) | 17.68 (1.78–175.58) | ||
| eGFR <90 ml/min per 1.73 m2 | 0.1581 | |||
| No | 1 | |||
| Yes | 0.40 (0.11–1.43) | |||
| Interstitial fibrosis = 0 | 0.0433 | |||
| No | 1 | |||
| Yes | 4.27 (1.04–17.46) | |||
| ≥2 Immunosuppressive drugs (except hydroxychloroquine and steroids) | 0.1416 | |||
| No | 1 | |||
| Yes | 0.39 (0.11–1.37) | |||
CI, confidence interval; eGFR, estimated glomerular filtration rate; EXT, exostosin; MN, membranous nephropathy; OR, odds ratio.
a
Variable forced in the multivariable model.